Authors:
Lozach, P
Vicariot, M
Le Niger, C
Pomey, MP
Lejeune, B
Ferec, C
Chaperon, J
Salmi, LR
Citation: P. Lozach et al., Evaluation of the reporting system of transfusion reactions at Brest University Hospital, TRANSF CL B, 8(4), 2001, pp. 343-349
Authors:
Loisel, S
Le Gall, C
Doucet, L
Ferec, C
Floch, V
Citation: S. Loisel et al., Contribution of plasmid DNA to hepatotoxicity after systemic administration of lipoplexes, HUM GENE TH, 12(6), 2001, pp. 685-696
Authors:
Barthellemy, S
Maurin, N
Roussey, M
Ferec, C
Murolo, S
Berthezene, P
Iovanna, JL
Dagorn, JC
Sarles, J
Citation: S. Barthellemy et al., Evaluation in 47,213 neonates of a strategy for neonatal screening of cystic fibrosis coupling pancreatitis-associated protein and immunoreactive trypsinogen assays., ARCH PED, 8(3), 2001, pp. 275-281
Citation: S. Loisel et al., Factors influencing the efficiency of lipoplexes mediated gene transfer inlung after intravenous administration, J LIPOS RES, 11(2-3), 2001, pp. 127-138
Authors:
Chen, JM
Cutler, C
Jacques, C
Boeuf, G
Denamur, E
Lecointre, G
Mercier, B
Cramb, G
Ferec, C
Citation: Jm. Chen et al., A combined analysis of the cystic fibrosis transmembrane conductance regulator: Implications for structure and disease models, MOL BIOL EV, 18(9), 2001, pp. 1771-1788
Citation: Jm. Chen et al., Molecular pathology and evolutionary and physiological implications of pancreatitis-associated cationic trypsinogen mutations, HUM GENET, 109(3), 2001, pp. 245-252
Authors:
Le Marechal, C
Audrezet, MP
Quere, I
Raguenes, O
Langonne, S
Ferec, C
Citation: C. Le Marechal et al., Complete and rapid scanning of the cystic fibrosis transmembrane conductance regulator (CFTR) gene by denaturing high-performance liquid chromatography (D-HPLC): major implications for genetic counselling, HUM GENET, 108(4), 2001, pp. 290-298
Authors:
Mura, C
Le Gac, G
Scotet, V
Raguenes, O
Mercier, AY
Ferec, C
Citation: C. Mura et al., Variation of iron loading expression in C282Y homozygous haemochromatosis probands and sib pairs, J MED GENET, 38(9), 2001, pp. 632-636
Authors:
Amaral, MD
Pacheco, P
Beck, S
Farinha, CM
Penque, D
Nogueira, P
Barreto, C
Lopes, B
Casals, T
Dapena, J
Gartner, S
Vasquez, C
Perez-Frias, J
Olveira, C
Cabanas, R
Estivill, X
Tzetis, M
Kanavakis, E
Doudounakis, S
Dork, T
Tummler, B
Girodon-Boulandet, E
Cazeneuve, C
Goossens, M
Blayau, M
Verlingue, C
Vieira, I
Ferec, C
Claustres, M
des Georges, M
Clavel, C
Birembaut, P
Hubert, D
Bienvenu, T
Adoun, M
Chomel, JC
De Boeck, K
Cuppens, H
Lavinha, J
Citation: Md. Amaral et al., Cystic fibrosis patients with the 3272-26A > G splicing mutation have milder disease than F508del homozygotes: a large European study, J MED GENET, 38(11), 2001, pp. 777-782
Authors:
Chen, JM
Mercier, B
Audrezet, MP
Raguenes, O
Quere, I
Ferec, C
Citation: Jm. Chen et al., Mutations of the pancreatic secretory trypsin inhibitor (PSTI) gene in idiopathic chronic pancreatitis, GASTROENTY, 120(4), 2001, pp. 1061-1063
Authors:
Chen, JM
Bis, AP
Le Bodic, L
Ruszniewski, P
Robaszkiewicz, M
Deprez, PH
Raguenes, O
Quere, I
Andriulli, A
Ferec, C
Citation: Jm. Chen et al., Mutational screening of the cationic trypsinogen gene in a large cohort ofsubjects with idiopathic chronic pancreatitis, CLIN GENET, 59(3), 2001, pp. 189-193
Authors:
Scotet, V
De Braekeleer, M
Audrezet, MP
Lode, L
Verlingue, C
Quere, I
Mercier, B
Dugueperoux, I
Codet, JP
Moineau, MP
Parent, P
Ferec, C
Citation: V. Scotet et al., Prevalence of CFTR mutations in hypertrypsinaemia detected through neonatal screening for cystic fibrosis, CLIN GENET, 59(1), 2001, pp. 42-47
Citation: G. Le Gac et al., Complete scanning of the hereditary hemochromatosis gene (HFE) by use of denaturing HPLC, CLIN CHEM, 47(9), 2001, pp. 1633-1640
Authors:
Guenin, E
Herve, AC
Floch, V
Loisel, S
Yaouanc, JJ
Clement, JC
Ferec, C
des Abbayes, H
Citation: E. Guenin et al., Cationic phosphonolipids containing quaternary phosphonium and arsonium groups for DNA transfection with good efficiency and low cellular toxicity, ANGEW CHEM, 39(3), 2000, pp. 629-631
Citation: Jm. Chen et C. Ferec, Gene conversion-like missense mutations in the human cationic trypsinogen gene and insights into the molecular evolution of the human trypsinogen family, MOL GEN MET, 71(3), 2000, pp. 463-469
Citation: Jm. Chen et al., Definition of a "functional R domain" of the cystic fibrosis transmembraneconductance regulator, MOL GEN MET, 71(1-2), 2000, pp. 245-249
Authors:
Rivard, SR
Mura, C
Simard, H
Simard, R
Grimard, D
Le Gac, G
Raguenes, O
Ferec, C
De Braekeleer, M
Citation: Sr. Rivard et al., Clinical and molecular aspects of juvenile hemochromatosis in Saguenay-Lac-Saint-Jean (Quebec, Canada), BL CELL M D, 26(1), 2000, pp. 10-14
Authors:
Claustres, M
Guittard, C
Bozon, D
Chevalier, F
Verlingue, C
Ferec, C
Girodon, E
Cazeneuve, C
Bienvenu, T
Lalau, G
Dumur, V
Feldmann, D
Bieth, E
Blayau, M
Clavel, C
Creveaux, I
Malinge, MC
Monnier, N
Malzac, P
Mittre, H
Chomel, JC
Bonnefont, JP
Iron, A
Chery, M
Des Georges, M
Citation: M. Claustres et al., Spectrum of CFTR mutations in cystic fibrosis and in congenital absence ofthe vas deferens in France, HUM MUTAT, 16(2), 2000, pp. 143-156